Adenylosuccinic acid (ASA-001)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adenylosuccinic acid (ASA-001), covering 2026-04-07 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1b Study of Adenylosuccinic Acid (ASA-001) for Adenylosuccinate Synthase 1 (ADSS1) Deficient Myopathy. [Phase 1]